BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit

Rosen Law Firm announced a securities class action lawsuit against Beta Bionics (NASDAQ: BBNX) on behalf of investors who purchased shares between July 30, 2025 and February 24, 2026. The announcement creates litigation and potential reputational risk for the diabetes-technology company, though the release provides no allegations, damages estimate, or financial impact details.